Announcements Trials

Browse Landscape

Status

Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 3 Gynecologic 2 Gastrointestinal 2 Tumor-Agnostic 1 Other solid neoplasm 1 Head & Neck 1 Genitourinary 1 Dermatologic 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 86 pembrolizumab 76 Specimen Handling 75 enzalutamide 55 Radiosurgery 55 Radiotherapy 51 Docetaxel 50 Androgen Antagonists 47 Gemcitabine 42 Nivolumab 39 darolutamide 37 Prednisone 35 enfortumab vedotin 32 Abiraterone Acetate 31 Cisplatin 30 Biopsy 30 Carboplatin 29 cabozantinib 28 Standard of Care 28 apalutamide 27 Pluvicto 26 abiraterone 25 Blood Specimen Collection 25 Radiation 23 Leuprolide 23 Ipilimumab 22 X-Rays 18 relugolix 17 Triptorelin Pamoate 17 Surveys and Questionnaires 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Histocompatibility Testing × Genitourinary × Clear all

NCT05577689 2025-06-05

NTTPro

Fudan University

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡